Semaglutide—Medical Weight Loss
with Ongoing Clinical Guidance

Appetite changes: Most patients notice reduced appetite and increased satiety within the first 1-2 weeks of treatment, even at the starting dose of 0.25 mg.

Weight loss: Meaningful weight loss typically begins within 4-8 weeks. In clinical trials, patients lost an average of 5-10% of their body weight by month 3, with continued weight loss through month 6 and beyond.

Metabolic benefits: Improvements in blood sugar control and other metabolic markers may be observed within 4-12 weeks of treatment.

Individual results vary based on starting weight, adherence to lifestyle modifications, and individual metabolic factors.

Gastrointestinal effects are the most common, particularly nausea (20-44% of patients), vomiting, diarrhea, and constipation. These typically:

• Peak during the first few weeks of treatment or dose increases
• Gradually improve as your body adjusts to the medication
• Are generally mild to moderate in severity

Management strategies:

• Eat smaller, more frequent meals
• Avoid high-fat, greasy, or spicy foods
• Stay well-hydrated
• Take medication at bedtime if nausea occurs
• Consider ginger supplements (with provider approval)

When to contact your provider: Persistent vomiting, severe abdominal pain, signs of dehydration, or any side effects that interfere with daily activities.

If you remember within 5 days: Take the missed dose as soon as possible, then continue with your regular weekly schedule.

If more than 5 days have passed: Skip the missed dose and take your next dose on the regularly scheduled day. Do not take two doses within 3 days of each other.

Important considerations:

• Never take two doses at the same time to make up for a missed dose
• If you frequently miss doses, discuss with your provider about strategies to improve adherence
• Set reminders on your phone or use a medication tracking app
• Consider changing your injection day if your current schedule is difficult to maintain

Tip: Choose a consistent day and time each week that fits your routine. Many patients find Sunday evenings or Monday mornings work well.

Treatment discontinuation: Current evidence suggests that semaglutide's benefits are maintained only while taking the medication. Most patients experience weight regain after stopping treatment.

Dose reduction options: Some patients may be able to maintain their weight loss on a lower maintenance dose. This should be done gradually under medical supervision:

• Reduce by one dose level every 4-8 weeks
• Monitor weight stability at each dose reduction
• Return to previous dose if weight regain occurs

Long-term approach: Many patients find that ongoing treatment at the lowest effective dose provides the best long-term weight maintenance, similar to how other chronic conditions require ongoing management.

Lifestyle maintenance: Regardless of medication status, maintaining healthy eating habits and regular physical activity remains crucial for long-term success.

Efficacy comparison: Semaglutide has demonstrated superior weight loss compared to older medications:

• Semaglutide: Average 15% body weight loss
• Liraglutide (Saxenda): Average 5-10% body weight loss
• Orlistat (Alli/Xenical): Average 3-5% body weight loss
• Phentermine: Average 3-5% body weight loss (short-term use only)

Advantages of semaglutide:

• Once-weekly injection vs. daily medications
• Superior weight loss efficacy
• Potential cardiovascular benefits
• Lower risk of significant drug interactions

Considerations: Higher cost compared to older medications, but potentially better value due to superior efficacy and convenience.

Clinical experience: Semaglutide has been studied for up to 2 years in weight management trials, with demonstrated safety and sustained efficacy over this period.

Long-term monitoring: Regular follow-up with your healthcare provider includes:

• Periodic assessment of treatment response and side effects
• Monitoring for rare but serious adverse events
• Regular laboratory monitoring if clinically indicated
• Evaluation of cardiovascular risk factors

Risk-benefit profile: For most patients, the cardiovascular and metabolic benefits of sustained weight loss outweigh the potential risks of long-term treatment.

Ongoing research: Long-term safety studies are ongoing to further characterize the safety profile beyond 2 years of treatment.

Nutrition recommendations:

• Focus on nutrient-dense, whole foods
• Prioritize lean proteins (25-30g per meal)
• Include plenty of non-starchy vegetables
• Choose complex carbohydrates over simple sugars
• Stay adequately hydrated (8-10 glasses of water daily)

Physical activity:

• Aim for 150 minutes of moderate-intensity aerobic activity weekly
• Include resistance training 2-3 times per week
• Start gradually and increase intensity over time
• Consider working with a qualified fitness professional

Behavioral support: Many patients benefit from working with a registered dietitian, therapist specializing in eating behaviors, or joining a structured weight loss program.

Remember: Semaglutide is most effective when combined with comprehensive lifestyle modifications. The medication helps make these changes more sustainable by reducing appetite and cravings.

Administration:

• Subcutaneous injection once weekly
• Injection sites: abdomen, thigh, or upper arm
• Rotate injection sites to prevent lipodystrophy
• Can be taken with or without food
• Pre-filled pen devices for easy self-administration

Storage requirements:

• Store unopened pens in refrigerator (36°F to 46°F)
• Do not freeze or shake
• After first use, can be stored at room temperature (up to 86°F) for up to 56 days
• Protect from light
• Dispose of pen after 56 days, even if not empty

Injection technique: Your healthcare provider will provide detailed training on proper injection technique, or you can access instructional videos through our patient portal.

Significant interactions:

• Insulin and sulfonylureas: May increase risk of hypoglycemia; dose adjustments may be needed
• Oral medications: Delayed gastric emptying may affect absorption of oral drugs taken simultaneously
• Warfarin: Monitor INR more frequently when starting or stopping semaglutide

Timing considerations:

• Take oral medications at least 1 hour before semaglutide injection when possible
• For medications requiring consistent timing (like levothyroxine), maintain consistent spacing from semaglutide

Important: Always inform your healthcare provider about all medications, supplements, and over-the-counter products you're taking before starting semaglutide.

Comprehensive clinical support:

• Board-certified providers specialized in weight management
• Personalized dose titration based on individual response
• Regular check-ins and monitoring throughout treatment
• 24/7 access to clinical support through secure messaging

Convenience features:

• Overnight shipping of medication and supplies
• Automatic refill coordination
• Flexible telehealth appointments
• Comprehensive patient education materials

Transparent pricing: No hidden fees, clear monthly pricing, and HSA/FSA eligibility for qualifying patients.

Quality assurance: All medications sourced from FDA-registered, licensed U.S. pharmacies with full traceability and quality controls.